Vanda Pharmaceuticals Inc Revenue per Employee (VNDA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vanda Pharmaceuticals Inc   (NASDAQ: VNDA)
 

Vanda Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 24.1% in the third quarter 2026, year on year to cumulative value of $229 million, Vanda Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 430,165. The productivity of Vanda Pharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 231 other companies have achieved higher revenue per employee. While Vanda Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 1276 to 1927. Vanda Pharmaceuticals Inc has 533 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VNDA Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 24.1 % -3.92 % 3.35 % 7.58 % 18.06 %
Sales per Employee (TTM) $ 430,165 404,730 408,597 405,450 397,887
VNDA's Total Ranking # 1927 # 1276 # 1094 # 1778 #
Seq. Revenue Change 38.17 % -2.3 % -9.61 % 1.7 % 6.97 %

VNDA Company Profile >> Back to VNDA Efficiency Comparisons >> Compare VNDA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 123
Healthcare Sector # 232
Overall Market # 1927

Revenue per Employee Statistics
High Average Low
$ 504,094 $ 309,735 $ 61,154
(Dec 31 2021)   (Jun 30 2013)



Financial Statements
Vanda Pharmaceuticals Inc 's Revenue MRQ $ 70 Millions Visit VNDA's Income Statement
Vanda Pharmaceuticals Inc 's Revenues TTM $ 229 Millions Visit VNDA's aggregate revenue growth
What are VNDA's Sales? Visit VNDA's Sales by Segment




Other Ratios
Vanda Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VNDA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VNDA's Competitors
Revenue per Employee for VNDA's Suppliers
Revenue per Employee for VNDA's Customers

You may also want to know
VNDA's Sales Growth Rates VNDA's Pe Price to earnings ratio VNDA's Receivables Turnover Ratio VNDA's Stock Quote
VNDA's Net Income Growth Rates VNDA's Ps Price to Sales ratio VNDA's Sales per Employee VNDA's Asset Turnover Ratio
VNDA's Net Margin VNDA's Pb Price to Book ratio VNDA's Financial Strength Ratios VNDA's Dividend Payout Ratio
Date modified: 2026-10-30T13:26:52+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.